An Overview of Medication for Opioid Use Disorder-At the end of the training participants will be able to answer the following questions What is a MAT/MOUD program? What is an OTP? - What is the pharmacist’s role with these programs? What medications are used for MAT/MOUD programs - Assessment? Dosing ? Side effects? REMS? What TN laws currently surround MAT/MOUD programs, specifically relating to prescribing and dispensing the medications?

At the end of the training participants will be able to answer the following questions What is a MAT/MOUD program? What is an OTP? - What is the pharmacist’s role with these programs? What medications are used for MAT/MOUD programs - Assessment? Dosing ? Side effects? REMS? What TN laws currently surround MAT/MOUD programs, specifically relating to prescribing and dispensing the medications?

Back to course

Video Transcription

Video Summary

Dr. Reed Finlayson and Dr. Nasheen Hossain from Vanderbilt University presented a session on medications for opioid use disorder funded by the Opioid Response Network. They discussed the history of pharmacists and doctors collaborating, the impact of opioid use disorder on the brain, and the rise of opioid-related deaths. The presentation focused on medications like buprenorphine, methadone, and naltrexone, highlighting their efficacy and dosing guidelines. They also addressed the stigma associated with addiction, the need for inclusive language, and the importance of continuous treatment post-release from incarceration. The session concluded with resources for clinicians and emphasized the role of proper training and access to care in combating the opioid crisis.

Keywords

opioid use disorder

buprenorphine

methadone

naltrexone

stigma

inclusive language

opioid crisis